| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2feed77ad2920b465a9409f31480591
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c3c65b018ce7acd6572dcfe1fbf8e0c |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16023
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5258
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-04 |
| filingDate |
2004-02-18^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ca84f37c54d6e715a23a432a8838dbe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8433aa9526b5146f7d2548ddde12b0ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d58b3c4fc06d5538b65bae8df35adbed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0a03b0997ac7707cc29c3e0926284dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd157f743201c632df4c46e4f43c84db |
| publicationDate |
2004-11-11^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2004224308-A1 |
| titleOfInvention |
Stabilized viral envelope proteins and uses thereof |
| abstract |
This invention provides an isolated nucleic acid which comprises a nucleotide segment having a sequence encoding a viral envelope protein comprising a viral surface protein and a corresponding viral transmembrane protein wherein the viral envelope protein contains one or more mutations in amino acid sequence that enhance the stability of the complex formed between the viral surface protein and transmembrane protein. This invention also provides a viral envelope protein comprising a viral surface protein and a corresponding viral transmembrane protein wherein the viral envelope protein contains one or more mutations in amino acid sequence that enhance the stability of the complex formed between the viral surface protein and transmembrane protein. This invention further provides methods of treating HIV-1 infection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011076298-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014039775-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7939083-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006094049-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7592014-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9938325-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010041875-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008274134-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006051373-A1 |
| priorityDate |
1999-06-25^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |